Bio Nano Consulting introduces beta version of COVID-19 Outbreak Management Tool
Bio Nano Consulting, a member of the AquAffirm Group, announces the introduction of the beta version of its advanced COVID-19 Outbreak Management Tool – a digital platform for mapping, modelling and managing the current coronavirus epidemic in the UK. Adapted from a GIS-enabled software mapping platform that has been in development for 18 months, this tool will help UK government healthcare officials, NHS directors, strategic planners and academic researchers to model, plan, prepare and act in real-time to manage the outbreak most effectively. The first version shows the cumulative number of confirmed coronavirus cases in real time for the 32 London boroughs; the link is: www.CORONA19.uk.
Future versions will shortly provide the same information for the rest of the UK.
The software tool will in time provide decision support across a range of areas of importance in managing the current outbreak, including:
Key features of the COVID-19 Outbreak Management Tool include:
AquAffirm is a London-based product development company commercialising technologies to address global biomedical and environmental issues. Offering both hardware and digital solutions, the company is focused on tackling some of the world’s most intractable problems. With a world class board comprising a PowderJect co-founder (Dr David Sarphie, CEO), a co-inventor of the blood glucose test (Prof Tony Cass of Imperial College), a world-renowned microwave engineer and physicist (Prof Gabriel Aeppli FRS of ETH in Switzerland) and an internationally-recognised former director of large UK laboratories (Prof John Wood FREng), AquAffirm is a leader in developing advanced technology solutions.
For more information, please contact Dr David Sarphie on +44 (0)7771 802145 or e-mail: email@example.com